Abstract
Drug-induced nephropathy (DN) is a common cause of kidney injury in outpatients and hospitalized patients, affecting approximately 20% of the adult population. DN occurs especially often when patients are treated with antibiotics, antiviral, antitumor drugs and nonsteroidal anti-inflammatory drugs. A detailed collection of pharmacological and allergological history and assessment of potential risk factors for drug nephrotoxicity are key to DN prevention and diagnosis. The article briefly covers the mechanisms of development and clinical phenotypes of DN, criteria for diagnosis, principles of patient management, including general prevention of DN and prevention of kidney injury associated with certain medications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
